対話型分析
マクロ分析
個別銘柄
アルファラボ
ユーティリティ
Menu
マイアクティビティ
JA
ログイン
JA
急騰分析
/
Hans Biomed Corp.
/
2026-05-14
▲ SURGE
Hans Biomed Corp.
+21.3%
042520
KRX
Healthcare
2026-05-14
27,900
終値
23,000
前日終値
+21.30%
騰落率
2.8x
出来高比
急騰の理由
제공된 뉴스 기사에서 Hans Biomed Corp.(042520)와 관련된 정보를 찾을 수 없습니다.
·
제공된 뉴스 기사에서 Hans Biomed Corp.(042520)와 관련된 정보를 찾을 수 없습니다.
関連ニュース
Neumora Therapeutics to Participate in 25th Annual Needham Virtu
Gurufocus
2026-04-06
After scrapping AXN-2510, Instil Bio hunts for new drug deals
Stocktitan
2026-03-27
Harvard Bioscience shares are trading higher after the company reported preliminary Q4 results, issued FY26 outlook and outlined its long-term strategic focus areas. - Harvard Bioscience (NASDAQ:HBIO)
Benzinga
2026-02-10
Fractyl Health sets March 24 call on 2025 results, business updates
Stocktitan
2026-03-17
Neumora lines up April 13 Needham healthcare conference webcast
Stocktitan
2026-04-06
テクニカル分析
シグナル
MACD弱気
SMA20下
主要指標
44.40
RSI (14)
29895.00
SMA 20
21655.12
Bollinger Lower
38134.88
Bollinger Upper
29895.00
Bollinger Mid
-3139.21
MACD
-2979.94
MACD Signal
-159.27
MACD Hist
銘柄詳細を見る
急騰銘柄一覧へ
ホーム
チャット
資産
履歴
メニュー
Hans Biomed Corp. +21.3% 急騰分析 (2026-05-14) | Alpha Lenz